APO Research
Talk to an analyst

APO RESEARCH · REPORT

Methylation Analysis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Methylation Analysis Market Outlook and Growth Opportunities 2026

16 January 2026191 pages

Choose your research edition.

Industry ResearchMethylation Analysis Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Methylation Analysis Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Methylation Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Methylation Analysis Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Methylation Analysis Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Methylation Analysis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Methylation Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Methylation Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Methylation Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Methylation Analysis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Methylation Analysis market include Berry Genomics, Illumina Inc., Diagenode, Novogene, Qiagen N.V., Oebiotech, RiboBio, Merck KGaA and BGI, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Methylation Analysis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Methylation Analysis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Methylation Analysis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Methylation Analysis market.

Methylation Analysis Segment by Company

Berry Genomics

Illumina Inc.

Diagenode

Novogene

Qiagen N.V.

Oebiotech

RiboBio

Merck KGaA

BGI

Seqhealth

Zymo Research Corporation

Epigentek

Promega Corporation

CD Genomics

BioCat GmbH

Methylation Analysis Segment by Type

DNA Methylation Sequencing

RNA Methylation Sequencing

Methylation Analysis Segment by Application

Clinical

Laboratory

Others

Methylation Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Methylation Analysis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Methylation Analysis key companies, revenue, market share, and recent developments.

3. To split the Methylation Analysis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Methylation Analysis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Methylation Analysis significant trends, drivers, influence factors in global and regions.

6. To analyze Methylation Analysis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methylation Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Methylation Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methylation Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Methylation Analysis industry.

Chapter 3: Detailed analysis of Methylation Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Methylation Analysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Methylation Analysis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Methylation Analysis Industry Trends Table 2. Methylation Analysis Industry Drivers Table 3. Methylation Analysis Industry Opportunities and Challenges Table 4. Methylation Analysis Industry Restraints Table 5. Global Methylation Analysis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Methylation Analysis Revenue Share by Company (2021-2026) Table 7. Global Methylation Analysis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Methylation Analysis Key Company Manufacturing Base & Headquarters Table 9. Global Methylation Analysis Company, Product Type & Application Table 10. Global Methylation Analysis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Methylation Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of DNA Methylation Sequencing Table 15. Significant Companies of RNA Methylation Sequencing Table 16. Global Methylation Analysis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Methylation Analysis Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Methylation Analysis Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Methylation Analysis Sales Value Share by Type (2021-2026) Table 20. Global Methylation Analysis Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Clinical Table 22. Significant Companies of Laboratory Table 23. Significant Companies of Others Table 24. Global Methylation Analysis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Methylation Analysis Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Methylation Analysis Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Methylation Analysis Sales Value Share by Application (2021-2026) Table 28. Global Methylation Analysis Sales Value Share by Application (2027-2032) Table 29. Global Methylation Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Methylation Analysis Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Methylation Analysis Sales Value Share by Region (2021-2026) Table 32. Global Methylation Analysis Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Methylation Analysis Sales Value Share by Region (2027-2032) Table 34. Global Methylation Analysis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Methylation Analysis Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Methylation Analysis Sales Value Market Share by Country (2021-2026) Table 37. Global Methylation Analysis Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Methylation Analysis Sales Value Market Share by Country (2027-2032) Table 39. Berry Genomics Company Information Table 40. Berry Genomics Business Overview Table 41. Berry Genomics Methylation Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Berry Genomics Methylation Analysis Product Portfolio Table 43. Berry Genomics Recent Development Table 44. Illumina Inc. Company Information Table 45. Illumina Inc. Business Overview Table 46. Illumina Inc. Methylation Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Illumina Inc. Methylation Analysis Product Portfolio Table 48. Illumina Inc. Recent Development Table 49. Diagenode Company Information Table 50. Diagenode Business Overview Table 51. Diagenode Methylation Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Diagenode Methylation Analysis Product Portfolio Table 53. Diagenode Recent Development Table 54. Novogene Company Information Table 55. Novogene Business Overview Table 56. Novogene Methylation Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Novogene Methylation Analysis Product Portfolio Table 58. Novogene Recent Development Table 59. Qiagen N.V. Company Information Table 60. Qiagen N.V. Business Overview Table 61. Qiagen N.V. Methylation Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Qiagen N.V. Methylation Analysis Product Portfolio Table 63. Qiagen N.V. Recent Development Table 64. Oebiotech Company Information Table 65. Oebiotech Business Overview Table 66. Oebiotech Methylation Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Oebiotech Methylation Analysis Product Portfolio Table 68. Oebiotech Recent Development Table 69. RiboBio Company Information Table 70. RiboBio Business Overview Table 71. RiboBio Methylation Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. RiboBio Methylation Analysis Product Portfolio Table 73. RiboBio Recent Development Table 74. Merck KGaA Company Information Table 75. Merck KGaA Business Overview Table 76. Merck KGaA Methylation Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merck KGaA Methylation Analysis Product Portfolio Table 78. Merck KGaA Recent Development Table 79. BGI Company Information Table 80. BGI Business Overview Table 81. BGI Methylation Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. BGI Methylation Analysis Product Portfolio Table 83. BGI Recent Development Table 84. Seqhealth Company Information Table 85. Seqhealth Business Overview Table 86. Seqhealth Methylation Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Seqhealth Methylation Analysis Product Portfolio Table 88. Seqhealth Recent Development Table 89. Zymo Research Corporation Company Information Table 90. Zymo Research Corporation Business Overview Table 91. Zymo Research Corporation Methylation Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Zymo Research Corporation Methylation Analysis Product Portfolio Table 93. Zymo Research Corporation Recent Development Table 94. Epigentek Company Information Table 95. Epigentek Business Overview Table 96. Epigentek Methylation Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Epigentek Methylation Analysis Product Portfolio Table 98. Epigentek Recent Development Table 99. Promega Corporation Company Information Table 100. Promega Corporation Business Overview Table 101. Promega Corporation Methylation Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Promega Corporation Methylation Analysis Product Portfolio Table 103. Promega Corporation Recent Development Table 104. CD Genomics Company Information Table 105. CD Genomics Business Overview Table 106. CD Genomics Methylation Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. CD Genomics Methylation Analysis Product Portfolio Table 108. CD Genomics Recent Development Table 109. BioCat GmbH Company Information Table 110. BioCat GmbH Business Overview Table 111. BioCat GmbH Methylation Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. BioCat GmbH Methylation Analysis Product Portfolio Table 113. BioCat GmbH Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Methylation Analysis Product Image Figure 2. Global Methylation Analysis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Methylation Analysis Market Size (2021-2032) & (US$ Million) Figure 4. Global Methylation Analysis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. DNA Methylation Sequencing Image Figure 8. RNA Methylation Sequencing Image Figure 9. Global Methylation Analysis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Methylation Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Methylation Analysis Sales Value Share by Type (2021-2032) Figure 12. Clinical Image Figure 13. Laboratory Image Figure 14. Others Image Figure 15. Global Methylation Analysis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Methylation Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Methylation Analysis Sales Value Share by Application (2021-2032) Figure 18. Global Methylation Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Methylation Analysis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Methylation Analysis Sales Value (2021-2032) & (US$ Million) Figure 21. North America Methylation Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Methylation Analysis Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Methylation Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Methylation Analysis Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Methylation Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Methylation Analysis Sales Value (2021-2032) & (US$ Million) Figure 27. South America Methylation Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Methylation Analysis Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Methylation Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Methylation Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Methylation Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Methylation Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Methylation Sequencing
  • RNA Methylation Sequencing
Applications
  • Clinical
  • Laboratory
  • Others
Companies covered
  • Berry Genomics
  • Illumina Inc.
  • Diagenode
  • Novogene
  • Qiagen N.V.
  • Oebiotech
  • RiboBio
  • Merck KGaA
  • BGI
  • Seqhealth
  • Zymo Research Corporation
  • Epigentek
  • Promega Corporation
  • CD Genomics
  • BioCat GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Methylation Analysis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Methylation Analysis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Methylation Analysis Market Dynamics
  1. 2.1 Methylation Analysis Industry Trends
  2. 2.2 Methylation Analysis Industry Drivers
  3. 2.3 Methylation Analysis Industry Opportunities and Challenges
  4. 2.4 Methylation Analysis Industry Restraints
3 Methylation Analysis Market by Company
  1. 3.1 Global Methylation Analysis Company Revenue Ranking in 2025
  2. 3.2 Global Methylation Analysis Revenue by Company (2021-2026)
  3. 3.3 Global Methylation Analysis Company Ranking (2024-2026)
  4. 3.4 Global Methylation Analysis Company Manufacturing Base and Headquarters
  5. 3.5 Global Methylation Analysis Company Product Type and Application
  6. 3.6 Global Methylation Analysis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Methylation Analysis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Methylation Analysis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Methylation Analysis Market by Type
  1. 4.1 Methylation Analysis Type Introduction
  2. 4.1.1 DNA Methylation Sequencing
  3. 4.1.2 RNA Methylation Sequencing
  4. 4.2 Global Methylation Analysis Sales Value by Type
  5. 4.2.1 Global Methylation Analysis Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Methylation Analysis Sales Value by Type (2021-2032)
  7. 4.2.3 Global Methylation Analysis Sales Value Share by Type (2021-2032)
5 Methylation Analysis Market by Application
  1. 5.1 Methylation Analysis Application Introduction
  2. 5.1.1 Clinical
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Methylation Analysis Sales Value by Application
  6. 5.2.1 Global Methylation Analysis Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Methylation Analysis Sales Value by Application (2021-2032)
  8. 5.2.3 Global Methylation Analysis Sales Value Share by Application (2021-2032)
6 Methylation Analysis Regional Value Analysis
  1. 6.1 Global Methylation Analysis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Methylation Analysis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Methylation Analysis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Methylation Analysis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Methylation Analysis Sales Value (2021-2032)
  7. 6.3.2 North America Methylation Analysis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Methylation Analysis Sales Value (2021-2032)
  10. 6.4.2 Europe Methylation Analysis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Methylation Analysis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Methylation Analysis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Methylation Analysis Sales Value (2021-2032)
  16. 6.6.2 South America Methylation Analysis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Methylation Analysis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Methylation Analysis Sales Value Share by Country, 2025 VS 2032
7 Methylation Analysis Country-level Value Analysis
  1. 7.1 Global Methylation Analysis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Methylation Analysis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Methylation Analysis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Methylation Analysis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Methylation Analysis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Methylation Analysis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Methylation Analysis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Methylation Analysis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Methylation Analysis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Methylation Analysis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Methylation Analysis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Methylation Analysis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Methylation Analysis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Methylation Analysis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Methylation Analysis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Methylation Analysis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Methylation Analysis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Methylation Analysis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Methylation Analysis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Methylation Analysis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Methylation Analysis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Methylation Analysis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Methylation Analysis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Methylation Analysis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Methylation Analysis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Methylation Analysis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Methylation Analysis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Methylation Analysis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Methylation Analysis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Methylation Analysis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Methylation Analysis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Methylation Analysis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Methylation Analysis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Methylation Analysis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Methylation Analysis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Berry Genomics
  2. 8.1.1 Berry Genomics Company Information
  3. 8.1.2 Berry Genomics Business Overview
  4. 8.1.3 Berry Genomics Methylation Analysis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Berry Genomics Methylation Analysis Product Portfolio
  6. 8.1.5 Berry Genomics Recent Developments
  7. 8.2 Illumina Inc.
  8. 8.2.1 Illumina Inc. Company Information
  9. 8.2.2 Illumina Inc. Business Overview
  10. 8.2.3 Illumina Inc. Methylation Analysis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Illumina Inc. Methylation Analysis Product Portfolio
  12. 8.2.5 Illumina Inc. Recent Developments
  13. 8.3 Diagenode
  14. 8.3.1 Diagenode Company Information
  15. 8.3.2 Diagenode Business Overview
  16. 8.3.3 Diagenode Methylation Analysis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Diagenode Methylation Analysis Product Portfolio
  18. 8.3.5 Diagenode Recent Developments
  19. 8.4 Novogene
  20. 8.4.1 Novogene Company Information
  21. 8.4.2 Novogene Business Overview
  22. 8.4.3 Novogene Methylation Analysis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novogene Methylation Analysis Product Portfolio
  24. 8.4.5 Novogene Recent Developments
  25. 8.5 Qiagen N.V.
  26. 8.5.1 Qiagen N.V. Company Information
  27. 8.5.2 Qiagen N.V. Business Overview
  28. 8.5.3 Qiagen N.V. Methylation Analysis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Qiagen N.V. Methylation Analysis Product Portfolio
  30. 8.5.5 Qiagen N.V. Recent Developments
  31. 8.6 Oebiotech
  32. 8.6.1 Oebiotech Company Information
  33. 8.6.2 Oebiotech Business Overview
  34. 8.6.3 Oebiotech Methylation Analysis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Oebiotech Methylation Analysis Product Portfolio
  36. 8.6.5 Oebiotech Recent Developments
  37. 8.7 RiboBio
  38. 8.7.1 RiboBio Company Information
  39. 8.7.2 RiboBio Business Overview
  40. 8.7.3 RiboBio Methylation Analysis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 RiboBio Methylation Analysis Product Portfolio
  42. 8.7.5 RiboBio Recent Developments
  43. 8.8 Merck KGaA
  44. 8.8.1 Merck KGaA Company Information
  45. 8.8.2 Merck KGaA Business Overview
  46. 8.8.3 Merck KGaA Methylation Analysis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck KGaA Methylation Analysis Product Portfolio
  48. 8.8.5 Merck KGaA Recent Developments
  49. 8.9 BGI
  50. 8.9.1 BGI Company Information
  51. 8.9.2 BGI Business Overview
  52. 8.9.3 BGI Methylation Analysis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BGI Methylation Analysis Product Portfolio
  54. 8.9.5 BGI Recent Developments
  55. 8.10 Seqhealth
  56. 8.10.1 Seqhealth Company Information
  57. 8.10.2 Seqhealth Business Overview
  58. 8.10.3 Seqhealth Methylation Analysis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Seqhealth Methylation Analysis Product Portfolio
  60. 8.10.5 Seqhealth Recent Developments
  61. 8.11 Zymo Research Corporation
  62. 8.11.1 Zymo Research Corporation Company Information
  63. 8.11.2 Zymo Research Corporation Business Overview
  64. 8.11.3 Zymo Research Corporation Methylation Analysis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Zymo Research Corporation Methylation Analysis Product Portfolio
  66. 8.11.5 Zymo Research Corporation Recent Developments
  67. 8.12 Epigentek
  68. 8.12.1 Epigentek Company Information
  69. 8.12.2 Epigentek Business Overview
  70. 8.12.3 Epigentek Methylation Analysis Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Epigentek Methylation Analysis Product Portfolio
  72. 8.12.5 Epigentek Recent Developments
  73. 8.13 Promega Corporation
  74. 8.13.1 Promega Corporation Company Information
  75. 8.13.2 Promega Corporation Business Overview
  76. 8.13.3 Promega Corporation Methylation Analysis Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Promega Corporation Methylation Analysis Product Portfolio
  78. 8.13.5 Promega Corporation Recent Developments
  79. 8.14 CD Genomics
  80. 8.14.1 CD Genomics Company Information
  81. 8.14.2 CD Genomics Business Overview
  82. 8.14.3 CD Genomics Methylation Analysis Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CD Genomics Methylation Analysis Product Portfolio
  84. 8.14.5 CD Genomics Recent Developments
  85. 8.15 BioCat GmbH
  86. 8.15.1 BioCat GmbH Company Information
  87. 8.15.2 BioCat GmbH Business Overview
  88. 8.15.3 BioCat GmbH Methylation Analysis Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BioCat GmbH Methylation Analysis Product Portfolio
  90. 8.15.5 BioCat GmbH Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst